Decazes, P.; Ammari, S.; De Prévia, A.; Mottay, L.; Lawrance, L.; Belkouchi, Y.; Benatsou, B.; Albiges, L.; Balleyguier, C.; Vera, P.;
et al. Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics 2023, 13, 205.
https://doi.org/10.3390/diagnostics13020205
AMA Style
Decazes P, Ammari S, De Prévia A, Mottay L, Lawrance L, Belkouchi Y, Benatsou B, Albiges L, Balleyguier C, Vera P,
et al. Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics. 2023; 13(2):205.
https://doi.org/10.3390/diagnostics13020205
Chicago/Turabian Style
Decazes, Pierre, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera,
and et al. 2023. "Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs" Diagnostics 13, no. 2: 205.
https://doi.org/10.3390/diagnostics13020205
APA Style
Decazes, P., Ammari, S., De Prévia, A., Mottay, L., Lawrance, L., Belkouchi, Y., Benatsou, B., Albiges, L., Balleyguier, C., Vera, P., & Lassau, N.
(2023). Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs. Diagnostics, 13(2), 205.
https://doi.org/10.3390/diagnostics13020205
